SPHK1 and breast carcinoma: In estrogen receptor positive (ER+) tumors high S1PR1 and S1PR3 were reported to be causally associated with tamoxifen resistance and poor prognosis [92], and in vitro, in ER+ MCF-7 breast cancer cells, the SphK1/S1PR3 loop promoted breast cancer progression and migration [94].